Y. Qu

A Comprehensive Understanding of the Genomic Bone Tumor Landscape: A Multicenter Prospective Study

Jingnan Shen, Junqiang Yin, Zixiong Lei, 2022, Frontiers in Oncology.

Genomic profiling and the impact of MUC19 mutation in hepatoid adenocarcinoma of the stomach

Baofeng Lian, Mengxuan Zhu, Tianshu Liu, 2022, Cancer communications.

Pathogenic and Targetable Genetic Alterations in Resected Recurrent Undifferentiated Pleomorphic Sarcomas Identified by Targeted Next-generation Sequencing

Jian Wang, B. Zheng, Ying-qiang Shi, 2019, Cancer Genomics & Proteomics.

Molecular signatures of BRCAness analysis identifies PARP inhibitor Niraparib as a novel targeted therapeutic strategy for soft tissue Sarcomas

Dung-Fang Lee, Jingnan Shen, Gang Huang, 2020, Theranostics.

Identification of a novel EHBP1-MET fusion in an intrahepatic cholangiocarcinoma responding to crizotinib.

Tianshu Liu, Yiyi Yu, Qing Liu, 2020, The oncologist.

Toripalimab with chemotherapy as first-line treatment for advanced biliary tract tumors: Update analytic results of an open-label phase II clinical study (JS001-ZS-BC001).

Qian Li, Tianshu Liu, Yan Wang, 2021, Journal of Clinical Oncology.